CORDIS - Forschungsergebnisse der EU
CORDIS
Inhalt archiviert am 2024-06-18

Novel approaches for the development of customized skin treatments and services (Test case: Dead Sea Minerals and Conventional drugs)

Ziel

Economical and health interests of skin problems are fast growing issues in Europe, following the remarkable extension in life expectancy in western countries, together with the increased awareness of UV radiation risks. Personalized health care approach has been discussed over the past few years and had been accompanied by developing innovative technologies capable of identifying specific biomarkers, supporting a personalized diagnosis and treatments, especially concerning bio-compatibility of drugs. Skin Treat intends to develop and validate nano-chemical and bio- technologies to achieve an accurate matching of drugs, and drug delivery vehicles, to skin diseases and sub pathogenic skin conditions in their individual context. The project will design novel generation of pharmaceutical products, as well as consumer personalized service, in order to fit customers’ tailored needs with a support of strategic consortium based on partnership among SMEs and research organizations. The development of personalized skin therapy protocols requires achieving an accurate diagnostics of skin condition and an extensive analysis of biological markers. Non invasive methods as well as minimal invasive skin sampling, will support the establishment of a range of biological profiles corresponding to skin diseases and skin sub pathologic conditions. Statistical processing of these data will allow defining biomarkers patterns specifically associated with given clinical conditions. A bio-informatics data mining protocol will be elaborated, together with multifunctional biomarker analysis software, to build a refined, personalized diagnosis method. Finally, the computer data analysis will yield a decision support system (DSS) to assist dermatologists, chemist and clients for prescription of personalized treatment. Skin Treat concept will be evaluated by a wet pilot study of the whole ervice chain on a few, selected skin disorders like psoriasis, contact dermatitis, and UV skin photo-aging damages.

Aufforderung zur Vorschlagseinreichung

FP7-NMP-2007-SME-1
Andere Projekte für diesen Aufruf anzeigen

Koordinator

AHAVA DEAD SEA LABORATORIES LTD
EU-Beitrag
€ 559 575,00
Adresse
ARAVA STREET 1
70150 Airport City
Israel

Auf der Karte ansehen

Aktivitätstyp
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Kontakt Verwaltung
Ofer Achdut (Mr.)
Links
Gesamtkosten
Keine Daten

Beteiligte (14)